Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Consult Clin Psychol. 2014 Jul 7;82(6):1034–1048. doi: 10.1037/a0037212

Table 1.

Demographic and Clinical Characteristics of Randomized Participants

Characteristic TOTAL CBT ACT WL F value
or χ²
p
Gender (Female) 45.98%
(40/87)
42.42%
(14/33)
48.28%
(14/29)
48.00%
(12/25)
.27 .873
Age, in yearsb 28.37
(6.76)
Range: 19–44
29.80
(7.42)
27.42
(5.56)
27.64
(7.08)
1.16 .320
Education, in years 15.04
(1.95)
Range: 11–19
15.55
(1.82)
15.00
(1.87)
14.44
(2.10)
2.36 .100
Marital Status 6.91 .141
  Married/Cohabiting 11.49%
(10/87)
21.21%
(7/33)
0.00%
(0/29)
12.00%
(3/25)
  Single 79.31%
(69/87)
69.70%
(23/33)
89.66%
(26/29)
80.00%
(20/25)
  Other 9.20%
(8/87)
9.09%
(3/33)
10.34%
(3/29)
8.00%
(2/25)
Reported race/ethnicitya 1.02 .602
  White 50.57%
(44/87)
57.58%
(19/33)
48.28%
(14/29)
44.00%
(11/25)
  Hispanic/ Latino/a 17.24%
(15/87)
12.12%
(4/33)
17.24%
(5/29)
24.00%
(6/25)
  African-American/
  Black
2.30%
(2/87)
3.03%
(1/33)
3.45%
(1/29)
0.00%
(0/25)
  Asian-American/ Pacific
  Islander
18.39%
(16/87)
15.15%
(5/33)
20.69%
(6/29)
20.00%
(5/25)
Children (1+) 5.75%
(5/87)
9.09%
(3/33)
3.45%
(1/29)
4.00%
(1/25)
1.01 .576
Social Phobia clinical
severity rating (mean)
5.59
(.97)
Range: 4–7
5.73
(.91)
5.45
(1.02)
5.56
(1.00)
.64 .528
Currently on psychotropic
medicationc
32.18%
(28/87)
27.27%
(9/33)
27.59%
(8/29)
44.00%
(11/25)
2.24 .325
Comorbid anxiety disorder
(1+) d
22.99%
(20/87)
27.27%
(9/33)
27.59%
(8/29)
12.00%
(3/20)
2.39 .302
Comorbid depressive
disorder d
18.39%
(16/87)
15.15%
(5/33)
20.69%
(6/29)
20.00%
(5/25)
.38 .829
Comorbid anxiety or
depressive disorder
22.99%
(20/87)
24.24%
(8/33)
20.69%
(6/29)
24.00%
(6/25)
.13 .937
Comorbid anxiety and
depressive disorder
9.20%
(8/87)
9.09%
(3/33)
13.79%
(4/29)
4.00%
(1/25)
1.54 .462
a

For race/ ethnicity, analyses assessed group differences in minority versus white status.

b

Demographic data was missing for 1 P.

c

Medications include SSRIs/SNRIs, other antidepressants/mood stabilizers, benzodiazepines and prn medications

d

Comorbidity was defined as a clinical severity rating of 4 or above on the ADIS